These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 25419573)
1. Tumor necrosis factor-α sensitizes breast cancer cells to natural products with proteasome-inhibitory activity leading to apoptosis. Lu L; Shi W; Deshmukh RR; Long J; Cheng X; Ji W; Zeng G; Chen X; Zhang Y; Dou QP PLoS One; 2014; 9(11):e113783. PubMed ID: 25419573 [TBL] [Abstract][Full Text] [Related]
2. IRF-1 inhibits NF-κB activity, suppresses TRAF2 and cIAP1 and induces breast cancer cell specific growth inhibition. Armstrong MJ; Stang MT; Liu Y; Yan J; Pizzoferrato E; Yim JH Cancer Biol Ther; 2015; 16(7):1029-41. PubMed ID: 26011589 [TBL] [Abstract][Full Text] [Related]
3. Triptolide sensitizes human breast cancer cells to tumor necrosis factor‑α‑induced apoptosis by inhibiting activation of the nuclear factor‑κB pathway. Cheng X; Shi W; Zhao C; Zhang D; Liang P; Wang G; Lu L Mol Med Rep; 2016 Apr; 13(4):3257-64. PubMed ID: 26935527 [TBL] [Abstract][Full Text] [Related]
4. Withaferin A inhibits the proteasome activity in mesothelioma in vitro and in vivo. Yang H; Wang Y; Cheryan VT; Wu W; Cui CQ; Polin LA; Pass HI; Dou QP; Rishi AK; Wali A PLoS One; 2012; 7(8):e41214. PubMed ID: 22912669 [TBL] [Abstract][Full Text] [Related]
5. Combined treatment with verrucarin A and tumor necrosis factor-α sensitizes apoptosis by overexpression of nuclear factor-kappaB-mediated Fas. Jayasooriya RGPT; Moon DO; Park SR; Choi YH; Asami Y; Kim MO; Jang JH; Kim BY; Ahn JS; Kim GY Environ Toxicol Pharmacol; 2013 Sep; 36(2):303-310. PubMed ID: 23708311 [TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor-α-induced apoptosis of gastric cancer MKN28 cells: accelerated degradation of the inhibitor of apoptosis family members. Kitagawa M; Shiozaki A; Ichikawa D; Nakashima S; Kosuga T; Konishi H; Komatsu S; Fujiwara H; Okamoto K; Otsuji E Arch Biochem Biophys; 2015 Jan; 566():43-8. PubMed ID: 25513960 [TBL] [Abstract][Full Text] [Related]
7. A small molecule Smac-mimic compound induces apoptosis and sensitizes TRAIL- and etoposide-induced apoptosis in breast cancer cells. Bockbrader KM; Tan M; Sun Y Oncogene; 2005 Nov; 24(49):7381-8. PubMed ID: 16044155 [TBL] [Abstract][Full Text] [Related]
8. Sulforaphane suppresses TNF-alpha-mediated activation of NF-kappaB and induces apoptosis through activation of reactive oxygen species-dependent caspase-3. Moon DO; Kim MO; Kang SH; Choi YH; Kim GY Cancer Lett; 2009 Feb; 274(1):132-42. PubMed ID: 18952368 [TBL] [Abstract][Full Text] [Related]
9. Down-regulation of estrogen receptor-alpha and rearranged during transfection tyrosine kinase is associated with withaferin a-induced apoptosis in MCF-7 breast cancer cells. Zhang X; Mukerji R; Samadi AK; Cohen MS BMC Complement Altern Med; 2011 Oct; 11():84. PubMed ID: 21978374 [TBL] [Abstract][Full Text] [Related]
10. Celastrol synergistically enhances temozolomide cytotoxicity in melanoma cells. Chen M; Rose AE; Doudican N; Osman I; Orlow SJ Mol Cancer Res; 2009 Dec; 7(12):1946-53. PubMed ID: 19934274 [TBL] [Abstract][Full Text] [Related]
11. Lipopolysaccharides-stimulated macrophage products enhance Withaferin A-induced apoptosis via activation of caspases and inhibition of NF-κB pathway in human cancer cells. Piao L; Canguo Z; Wenjie L; Xiaoli C; Wenli S; Li L Mol Immunol; 2017 Jan; 81():92-101. PubMed ID: 27915154 [TBL] [Abstract][Full Text] [Related]
12. Protein kinase C inhibition and x-linked inhibitor of apoptosis protein degradation contribute to the sensitization effect of luteolin on tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in cancer cells. Shi RX; Ong CN; Shen HM Cancer Res; 2005 Sep; 65(17):7815-23. PubMed ID: 16140950 [TBL] [Abstract][Full Text] [Related]
13. Withaferin A-induced apoptosis in human breast cancer cells is associated with suppression of inhibitor of apoptosis family protein expression. Hahm ER; Singh SV Cancer Lett; 2013 Jun; 334(1):101-8. PubMed ID: 22935676 [TBL] [Abstract][Full Text] [Related]
14. Rosmarinic acid sensitizes cell death through suppression of TNF-alpha-induced NF-kappaB activation and ROS generation in human leukemia U937 cells. Moon DO; Kim MO; Lee JD; Choi YH; Kim GY Cancer Lett; 2010 Feb; 288(2):183-91. PubMed ID: 19619938 [TBL] [Abstract][Full Text] [Related]
15. Role of A20 in cIAP-2 protection against tumor necrosis factor α (TNF-α)-mediated apoptosis in endothelial cells. Guo S; Messmer-Blust AF; Wu J; Song X; Philbrick MJ; Shie JL; Rana JS; Li J Int J Mol Sci; 2014 Mar; 15(3):3816-33. PubMed ID: 24595242 [TBL] [Abstract][Full Text] [Related]
16. Induction of cell cycle arrest and apoptosis by the proteasome inhibitor PS-341 in Hodgkin disease cell lines is independent of inhibitor of nuclear factor-kappaB mutations or activation of the CD30, CD40, and RANK receptors. Zheng B; Georgakis GV; Li Y; Bharti A; McConkey D; Aggarwal BB; Younes A Clin Cancer Res; 2004 May; 10(9):3207-15. PubMed ID: 15131062 [TBL] [Abstract][Full Text] [Related]
17. TNF potentiates anticancer activity of bortezomib (Velcade) through reduced expression of proteasome subunits and dysregulation of unfolded protein response. Nowis D; McConnell EJ; Dierlam L; Palamarchuk A; Lass A; Wójcik C Int J Cancer; 2007 Jul; 121(2):431-41. PubMed ID: 17373661 [TBL] [Abstract][Full Text] [Related]
18. Pinitol targets nuclear factor-kappaB activation pathway leading to inhibition of gene products associated with proliferation, apoptosis, invasion, and angiogenesis. Sethi G; Ahn KS; Sung B; Aggarwal BB Mol Cancer Ther; 2008 Jun; 7(6):1604-14. PubMed ID: 18566231 [TBL] [Abstract][Full Text] [Related]
19. Celastrol, a novel triterpene, potentiates TNF-induced apoptosis and suppresses invasion of tumor cells by inhibiting NF-kappaB-regulated gene products and TAK1-mediated NF-kappaB activation. Sethi G; Ahn KS; Pandey MK; Aggarwal BB Blood; 2007 Apr; 109(7):2727-35. PubMed ID: 17110449 [TBL] [Abstract][Full Text] [Related]
20. Smac mimetic Birinapant induces apoptosis and enhances TRAIL potency in inflammatory breast cancer cells in an IAP-dependent and TNF-α-independent mechanism. Allensworth JL; Sauer SJ; Lyerly HK; Morse MA; Devi GR Breast Cancer Res Treat; 2013 Jan; 137(2):359-71. PubMed ID: 23225169 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]